Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1.

Hexamethylenebisacetamide (HMBA), a potent inducer of differentiation of transformed cells such as murine erythroleukemia cells, causes a prolongation of the G1 phase of the cell cycle during which commitment to terminal differentiation is first detected. Removal of HMBA prior to the G1 phase aborts...

Full description

Saved in:
Bibliographic Details
Main Authors: Kiyokawa, H, Richon, V M, Venta-Perez, G, Rifkind, R A, Marks, P A
Format: Artigo
Language:Inglês
Published: 1993
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC47009/
https://ncbi.nlm.nih.gov/pubmed/8341693
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items